-
1
المؤلفون: Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Anne-Marie F van der Kevie-Kersemaekers, Ludo M Evers, Fransien de Boer, Harry R Koene, John Schreurs, Marjolein van der Klift, Gerjo A Velders, Ellen van der Spek, Hanneke M van der Straaten, Mels Hoogendoorn, Michel van Gelder, Eduardus F M Posthuma, Hein P J Visser, Ilse Houtenbos, Cecile A M Idink, Djamila E Issa, Ellen C Dompeling, Henk C T van Zaanen, Hendrik Veelken, Henriette Levenga, Lidwine W Tick, Wim E Terpstra, Sanne H Tonino, Michelle Boyer, Mehrdad Mobasher, Mark-David Levin, Arnon P Kater
المساهمون: Human Genetics, ARD - Amsterdam Reproduction and Development, Clinical Haematology, AII - Cancer immunology, CCA - Cancer Treatment and Quality of Life, Experimental Immunology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology
المصدر: The Lancet Haematology, 9(3), e190-e199. Lancet Publishing Group
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTDمصطلحات موضوعية: Male, Sulfonamides, Adolescent, FLOW, MINIMAL RESIDUAL DISEASE, Hematology, QUANTIFICATION, Antibodies, Monoclonal, Humanized, Bridged Bicyclo Compounds, Heterocyclic, GUIDELINES, DIAGNOSIS, Leukemia, Lymphocytic, Chronic, B-Cell, MRD, CHLORAMBUCIL, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, RITUXIMAB, CLL
وصف الملف: application/pdf
-
2
المؤلفون: Arnon P Kater, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Johan A Dobber, Christian B Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Christian Brieghel, Mattias Mattsson, Mar Bellido, Hoa T T Tran, Kazem Nasserinejad, Carsten U Niemann
المساهمون: Hematology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Human Genetics, ARD - Amsterdam Reproduction and Development
المصدر: The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group
Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0
Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC
The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Groupمصطلحات موضوعية: Sulfonamides, BCL2, Neoplasm, Residual, Adenine, PROLIFERATION, MULTICENTER, Bridged Bicyclo Compounds, Heterocyclic, BCR, Leukemia, Lymphocytic, Chronic, B-Cell, 1ST-LINE TREATMENT, Pyrimidines, Piperidines, Oncology, Antineoplastic Combined Chemotherapy Protocols, CYCLOPHOSPHAMIDE, CELLS, Humans, Pyrazoles, RITUXIMAB, FLUDARABINE, CLL
وصف الملف: application/pdf
-
3
المؤلفون: Mark-David Levin, Julie Dubois, Rogier Mous, Ellen C Dompeling, Hoa T. T. Tran, Mar Bellido, Christian Bjørn Poulsen, Juha Ranti, Sabina Kersting, Ida Schjødt, Arnon P. Kater, Ann Janssens, Henrik Frederiksen, Clemens Mellink, Johan A. Dobber, Mattias Mattsson, Carsten Utoft Niemann, Lisbeth Enggaard, Gerrit J Veldhuis, Kazem Nasserinejad
المساهمون: Hematology, Human Genetics, AII - Cancer immunology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life
المصدر: Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
Blood, 137(8), 1117-1120. American Society of Hematology
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608مصطلحات موضوعية: Oncology, medicine.medical_specialty, Science & Technology, Venetoclax, business.industry, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, 1ST-LINE TREATMENT, chemistry.chemical_compound, chemistry, Ibrutinib, Internal medicine, Relapsed refractory, medicine, RITUXIMAB, business, Life Sciences & Biomedicine
وصف الملف: application/pdf; Print
-
4
المؤلفون: Christian Brieghel, Lisbeth Enggaard, Clemens Mellink, Ellen C Dompeling, Christian Bjørn Poulsen, Arnon P. Kater, Juha Ranti, Sabina Kersting, Hoa Thi Tuyet Tran, Kazem Nasserinejad, Rogier Mous, Ida Schjødt, Johan A. Dobber, Julie Dubois, Ann Janssens, Henrik Frederiksen, Carsten Utoft Niemann, Gerrit J Veldhuis, Mark-David Levin, Mattias Mattsson, Mar Bellido
المصدر: Niemann, C U, Dubois, J, Brieghel, C, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Juha Ranti, J, Mattsson, M, Bellido, M, Nasserinejad, K, Tran, H T T, Levin, M-D & Kater, A P 2021, ' Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD – Primary Analysis from the Randomized Phase II Vision HO141 Trial ', Blood, vol. 138, no. Supplement 1, 69 . https://doi.org/10.1182/blood-2021-148630
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Venetoclax, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, chemistry.chemical_compound, chemistry, Internal medicine, Ibrutinib, Relapsed refractory, medicine, business
-
5
المؤلفون: Kazem Nasserinejad, Juha Ranti, Clemens Mellink, Carsten Utoft Niemann, Christian Bjørn Poulsen, Johan A. Dobber, Ann Janssens, Mark-David Levin, Henrik Frederiksen, Ellen C Dompeling, Rogier Mous, Arnon P. Kater, Ida Schjødt, Julie Dubois, Hoa T Tran, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Mattias Mattsson, Mar Bellido
المصدر: Niemann, C U, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Juha Ranti, J, Mattsson, M, Bellido, M, Tran, H T, Nasserinejad, K, Levin, M-D & Kater, A P 2019, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) – 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial ', Blood, vol. 134, no. Supplement 1, 4292 . https://doi.org/10.1182/blood-2019-124377
Niemann, C U, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Juha Ranti, J, Mattsson, M, Bellido, M, Tran, H T, Nasserinejad, K, Levin, M-D & Kater, A P 2019, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) – 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019-10/12/2019 . < https://ashpublications.org/blood/article/134/Supplement_1/4292/425636/Venetoclax-and-Ibrutinib-for-Patients-with >
University of Southern Denmarkمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Immunology, Population, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Maintenance therapy, Obinutuzumab, Internal medicine, medicine, education, health care economics and organizations, education.field_of_study, Intention-to-treat analysis, business.industry, Venetoclax, Cell Biology, Hematology, Interim analysis, Regimen, 030104 developmental biology, chemistry, Ibrutinib, business, 030215 immunology
-
6
المؤلفون: Aart Beeker, Peter E. Westerweel, Karin Klauke, Martin R. Schipperus, Arne de Kreuk, Cees G. Schaar, Eduardus F. M. Posthuma, Anja A. van Houten, Cees J. H. Gerrits, Leonie Strobbe, Ellen C. Dompeling, Claire van de Ree-Pellikaan
المصدر: European journal of haematologyREFERENCES. 103(5)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cardiovascular risk factors, Hematocrit, 03 medical and health sciences, Leukocyte Count, 0302 clinical medicine, Polycythemia vera, Chart review, Internal medicine, medicine, Humans, In patient, Polycythemia Vera, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, medicine.diagnostic_test, business.industry, Platelet Count, Hematology, General Medicine, Phlebotomy, Middle Aged, medicine.disease, 030220 oncology & carcinogenesis, Treatment strategy, Female, business, 030215 immunology, Cohort study, Follow-Up Studies
-
7
المؤلفون: W L H Erwin, Smelt, Els T J, Wulffraat, Frans J G, Broekhoff, Ellen C, Dompeling, J Hanneke, Vos-Westerman
المصدر: Nederlands tijdschrift voor geneeskunde. 157(16)
مصطلحات موضوعية: Male, Midazolam, Palliative Care, Carcinoma, Squamous Cell, Conscious Sedation, Humans, Hypnotics and Sedatives, Pain, Mouth Neoplasms, Middle Aged, Propofol
-
8
المؤلفون: Martin J. W. IJsseldijk, Andre P. Abbes, Ellen C. Dompeling, Henk Engel, Annuska Strunk, Bert Dikkeschei, Robbert J. Slingerland, Jasper A. Remijn, Philip G. de Groot
المصدر: Clinical Chemical Laboratory Medicine. 45
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pathology, Platelet Aggregation, Platelet Function Tests, DNA Mutational Analysis, Clinical Biochemistry, Mutation, Missense, Biology, Hemorrhagic Disorders, P2Y12, Internal medicine, Extracellular, medicine, Humans, Platelet, Thrombus, Receptor, Receptors, Purinergic P2, Biochemistry (medical), General Medicine, medicine.disease, Adenosine receptor, Adenosine, Receptors, Purinergic P2Y12, Perfusion, Endocrinology, Blood Platelet Disorders, Collagen, medicine.drug